open access

Vol 19, No 3 (2015)
ORIGINAL PAPERS
Published online: 2015-09-29
Get Citation

Trends for beta-blockers use in a large cohort of Polish hypertensive patients — Pol-Fokus Study

Aleksander Prejbisz, Marek Klocek, Jerzy Gąsowski, Roman Topór-Mądry, Wiktoria Leśniak, Marek Kabat, Danuta Czarnecka, Kalina Kawecka-Jaszcz, Krzysztof Narkiewicz, Andrzej Januszewicz
DOI: 10.5603/AH.2015.0015
·
Arterial Hypertension 2015;19(3):120-128.

open access

Vol 19, No 3 (2015)
ORIGINAL PAPERS
Published online: 2015-09-29

Abstract

Background Beta-blockers remain one of the most frequently prescribed antihypertensive drug classes. The aim of the analysis was to evaluate characteristics of patients treated with beta-blockers and factors associated with the treatment of beta-blockers.

Material and methods We analysed the data from the large cross-sectional study evaluating 12,375 patients treated for hypertension for at least one year.

Results Overall, 7080 patients (57.2% of the whole group) were treated with beta-blockers. The rate of use of beta-blockers was higher in patients with diabetes (62.9 vs 55.6%), coronary artery disease (72.2 vs 46.4%), previous myocardial infarction (82.3 vs 54.1%), heart failure (73.1 vs 53.3%) and arrhythmias (73.1 vs 51.1%) than in patients without those conditions (all comparisons p < 0.001). Beta-blockers were used less frequently among patients with asthma/COPD than without asthma/COPD (54.0 vs 58.0%; p = 0.017). In patients aged 40 years and less, the compelling indications for these agents were found only in 21.7% of patients. In patients aged 40–65 years, none of compelling indications was found in 41.3% of patients. In patients 65 years or more, the most frequent compelling indications were coronary artery disease, previous myocardial infarction and heart failure, which were present in 70.1% of patients.

Conclusions High utilization rate of beta-blockers in patients with hypertension, only second to renin-angiotensin blockers, has been shown. In middle age and, especially, in older patients it might reflect high cardiovascular burden of those patients, including coexistence of established cardiac disease. In younger patients beta-blockers are used more frequently with none of the compelling indications present.

Abstract

Background Beta-blockers remain one of the most frequently prescribed antihypertensive drug classes. The aim of the analysis was to evaluate characteristics of patients treated with beta-blockers and factors associated with the treatment of beta-blockers.

Material and methods We analysed the data from the large cross-sectional study evaluating 12,375 patients treated for hypertension for at least one year.

Results Overall, 7080 patients (57.2% of the whole group) were treated with beta-blockers. The rate of use of beta-blockers was higher in patients with diabetes (62.9 vs 55.6%), coronary artery disease (72.2 vs 46.4%), previous myocardial infarction (82.3 vs 54.1%), heart failure (73.1 vs 53.3%) and arrhythmias (73.1 vs 51.1%) than in patients without those conditions (all comparisons p < 0.001). Beta-blockers were used less frequently among patients with asthma/COPD than without asthma/COPD (54.0 vs 58.0%; p = 0.017). In patients aged 40 years and less, the compelling indications for these agents were found only in 21.7% of patients. In patients aged 40–65 years, none of compelling indications was found in 41.3% of patients. In patients 65 years or more, the most frequent compelling indications were coronary artery disease, previous myocardial infarction and heart failure, which were present in 70.1% of patients.

Conclusions High utilization rate of beta-blockers in patients with hypertension, only second to renin-angiotensin blockers, has been shown. In middle age and, especially, in older patients it might reflect high cardiovascular burden of those patients, including coexistence of established cardiac disease. In younger patients beta-blockers are used more frequently with none of the compelling indications present.

Get Citation

Keywords

beta-blockers, hypertension, guidelines

About this article
Title

Trends for beta-blockers use in a large cohort of Polish hypertensive patients — Pol-Fokus Study

Journal

Arterial Hypertension

Issue

Vol 19, No 3 (2015)

Pages

120-128

Published online

2015-09-29

DOI

10.5603/AH.2015.0015

Bibliographic record

Arterial Hypertension 2015;19(3):120-128.

Keywords

beta-blockers
hypertension
guidelines

Authors

Aleksander Prejbisz
Marek Klocek
Jerzy Gąsowski
Roman Topór-Mądry
Wiktoria Leśniak
Marek Kabat
Danuta Czarnecka
Kalina Kawecka-Jaszcz
Krzysztof Narkiewicz
Andrzej Januszewicz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl